Advanced cardiac life support antiarrhythmic drugs

Cardiology Clinics

Volumn 20, Issue 1, 2002, Pages 79-87

  Kudenchuk, Peter J ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BRETYLIUM; LIDOCAINE; MAGNESIUM; PROCAINAMIDE;

CLINICAL PRACTICE; CRITICAL ILLNESS; EVIDENCE BASED MEDICINE; HEART ARREST; HUMAN; LONG TERM CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; STANDARDIZATION; SURVIVAL; TREATMENT PLANNING;

EID: 0036154889     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(03)00066-3     Document Type: Review

References (66)

1. Considerations for improving survival from out-of-hospital cardiac arrest
2. Estimating effectiveness of cardiac arrest interventions: A logistic regression survival model
3. Survival in patients found to have ventricular fibrillation after cardiac arrest witnessed outside hospital
4. Rhythm changes during resuscitation from ventricular fibrillation
5. Guidelines for advanced life support: A statement by the advanced life support working party of the European Resuscitation Council, 1992
6. Resuscitation outside the hospital: What's lacking
7. The use of antiarrhythmics in advanced cardiac life support
8. The coronary care unit: New perspectives and directions
9. Lidocaine in the prevention of primary ventricular fibrillation: A double-blind, randomized study of 212 consecutive patients
10. Ventricular fibrillation precipitated by cardiac catheterization
11. Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
12. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from randomized, controlled trials
13. Meta-analytic evidence against the prophylactic use of lidocaine in acute myocardial infarction
14. Reconsiderations of the routine and preferential use of lidocaine in the emergent treatment of ventricular arrhythmias
15. Electrophysiological properties of canine Purkinje fibers in one-day-old myocardial infarction
16. Effects of lidocaine on hypoxic and ischemic cardiac cells
17. Selective depression of the ischemic and hypoxic myocardium by lidocaine
18. Beneficial effect of lidocaine on ventricular electrical stability and spontaneous ventricular fibrillation during experimental myocardial infarction
19. Effect of lidocaine on the ventricular fibrillation threshold in the dog during acute ischemia and premature ventricular contractions
20. Mechanisms of the myocardial effects of bretylium
21. The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers
22. The effect of procainamide on excitability, refractoriness and conduction in the mammalian heart
23. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia
24. The role of magnesium in cardiac arrhythmias
25. Acute amiodarone terminates ventricular fibrillation by modifying cellular calcium homeostasis in isolated perfused rat hearts
26. The use of intravenous amiodarone in the acute therapy of life-threatening tachyarrhythmias
27. Evaluation of drugs for cardiac resuscitation
28. Resuscitation from ventricular fibrillation
29. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation
30. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: Experimental study
31. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs
32. Effect of procainamide on fibrillation threshold of normal and ischemic ventricles
33. Elevation of antiarrhythmic drugs on defibrillation energy requirements in dogs: Sodium channel block and action potential prolongation
34. Effect of lidocaine on energy requirements for transthoracic defibrillation: Experimental studies
35. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements
36. The effect of new antiarrhythymic drugs on defibrillation threshold
37. Effects of amiodarone and its active metabolite desethylamidarone on ventricular defibrillation threshold
38. Ventricular fibrillation precipitated by cardiac catheterization
39. Lidocaine in out-of-hospital ventricular fibrillation: Does it improve survival?
40. Lidocaine in prehospital countershock refractory ventricular fibrillation
41. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest?
42. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation
43. Chemical defibrillation of the human heart with bretylium tosylate
44. Bretylium tosylate as initial treatment for cardiopulmonary arrest: Randomized comparison with placebo
45. Comparison of bretylium tosylate and lidocaine in management of out-of-hospital ventricular fibrillation: A randomized clinical trial
46. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system
47. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent hemodynamically destabilizing ventricular tachycardia or fibrillation
48. Efficacy of bretylium tosylate for ventricular tachycardia
49. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation
50. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care
51. Intermittent intravenous procaine amide to treat ventricular arrhythmias
52. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias
53. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction
54. Dissociation of termination and prevention of induciblity of sustained ventricular tachycardia with infusion of procainamide: Evidence for distinct mechanisms
55. Effect of loading dose of procaine amide on left ventricular performance in man
56. Association of drug therapy with survival in cardiac arrest: Limited role of advanced cardiac life support drugs
57. Treatment of torsades de pointes with magnesium sulfate
58. Limited effect of magnesium sulfate on torsades de pointes ventricular tachycardia
59. Randomized trial of magnesium in in-hospital cardiac arrest
60. Magnesium in cardiac arrest
61. Magnesium levels in cardiac arrest victims: Relationship between magnesium levels and successful resuscitation
62. Intravenous Amiodarone Multicenter Group: Dose ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias
63. Intravenous Amiodarone Multicenter Group: Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent hemodynamically destabilizing ventricular tachycardia or fibrillation
64. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation
65. Amiodarone in out-of-hospital cardiac arrest